BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3120 related articles for article (PubMed ID: 15765032)

  • 1. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of pituitary adenomas].
    Mezosi E; Nemes O
    Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-functioning pituitary adenomas.
    Chanson P; Brochier S
    J Endocrinol Invest; 2005; 28(11 Suppl International):93-9. PubMed ID: 16625856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple pituitary hormone gradients from cavernous sinus sampling in patients with Cushing's disease.
    Yoshida Y; Sanno N; Teramoto A
    Acta Neurochir (Wien); 2000; 142(12):1339-44. PubMed ID: 11214626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Treatment of Pituitary Adenomas: A Review.
    Molitch ME
    JAMA; 2017 Feb; 317(5):516-524. PubMed ID: 28170483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy.
    Losa M; Fortunato M; Molteni L; Peretti E; Mortini P
    Minerva Endocrinol; 2008 Dec; 33(4):329-40. PubMed ID: 18923369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy in the multimodal treatment approach of pituitary adenoma.
    Becker G; Kocher M; Kortmann RD; Paulsen F; Jeremic B; Müller RP; Bamberg M
    Strahlenther Onkol; 2002 Apr; 178(4):173-86. PubMed ID: 12040754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyrotropin--TSH secreting pituitary tumor].
    Zieliński G; Podgórski JK; Warczyńska A; Koziarski A; Zgliczyński W
    Przegl Lek; 2002; 59(12):1018-23. PubMed ID: 12731380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid-stimulating hormone pituitary adenomas.
    Clarke MJ; Erickson D; Castro MR; Atkinson JL
    J Neurosurg; 2008 Jul; 109(1):17-22. PubMed ID: 18590428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
    Socin HV; Chanson P; Delemer B; Tabarin A; Rohmer V; Mockel J; Stevenaert A; Beckers A
    Eur J Endocrinol; 2003 Apr; 148(4):433-42. PubMed ID: 12656664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature.
    Minniti G; Esposito V; Piccirilli M; Fratticci A; Santoro A; Jaffrain-Rea ML
    Eur J Endocrinol; 2005 Dec; 153(6):723-35. PubMed ID: 16322376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A; Sanno N; Tahara S; Osamura YR
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyrotropin-secreting pituitary adenomas].
    Caron P
    Presse Med; 2009 Jan; 38(1):107-11. PubMed ID: 18980829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
    Hofstetter CP; Shin BJ; Mubita L; Huang C; Anand VK; Boockvar JA; Schwartz TH
    Neurosurg Focus; 2011 Apr; 30(4):E10. PubMed ID: 21456921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
    Ferone D; Lastoria S; Colao A; Varrella P; Cerbone G; Acampa W; Merola B; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1998 Jan; 83(1):248-52. PubMed ID: 9435450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 156.